{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T15:49:24Z","timestamp":1746114564175,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10067-020-05281-3","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T13:29:26Z","timestamp":1594733366000},"page":"775-782","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Multiple endocrine neoplasia type 1 revealed by a hip pathologic fracture"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6889-9687","authenticated-orcid":false,"given":"Maroua","family":"Slouma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maissa","family":"Abbes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rim","family":"Dhahri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noureddine","family":"Litaiem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nour","family":"Gueddiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issam","family":"Msekni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imen","family":"Gharsallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Metoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassem","family":"Louzir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"issue":"6","key":"5281_CR1","doi-asserted-by":"publisher","first-page":"F1000 Faculty R","DOI":"10.12688\/f1000research.7230.1","volume":"24","author":"A Falchetti","year":"2017","unstructured":"Falchetti A (2017) Genetics of multiple endocrine neoplasia type 1 syndrome: what\u2019s new and what\u2019s old. F1000 Res 24(6):F1000 Faculty Rev-73. https:\/\/doi.org\/10.12688\/f1000research.7230.1","journal-title":"F1000 Res"},{"issue":"10","key":"5281_CR2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/archsurg.134.10.1119","volume":"134","author":"JR Burgess","year":"1999","unstructured":"Burgess JR, David R, Greenaway TM, Parameswaran V, Shepherd JJ (1999) Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy. Arch Surg Chic Ill 1960 134(10):1119\u20131123. https:\/\/doi.org\/10.1001\/archsurg.134.10.1119","journal-title":"Arch Surg Chic Ill 1960"},{"issue":"1","key":"5281_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1385\/ENDO:12:1:11","volume":"12","author":"M Sato","year":"2000","unstructured":"Sato M, Kobayashi T, Dobashi H, Ohye H, Matsubara S, Murao K, Miyauchi A, Kobayashi S, Takahara J (2000) Large goiter and multiple rib tumors. Endocrine 12(1):11\u201314. https:\/\/doi.org\/10.1385\/ENDO:12:1:11","journal-title":"Endocrine"},{"key":"5281_CR4","doi-asserted-by":"publisher","first-page":"86s","DOI":"10.1016\/s0753-3322(00)80020-7","volume":"54","author":"M Sato","year":"2000","unstructured":"Sato M, Miyauchi A, Takahara J (2000) Clinical aspects of hyperparathyroidism in Japanese multiple endocrine neoplasia type 1. Biomed Pharmacother 54:86s\u201389s. https:\/\/doi.org\/10.1016\/s0753-3322(00)80020-7","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"5281_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1507\/endocrj.52.277","volume":"52","author":"M Katai","year":"2005","unstructured":"Katai M, Sakurai A, Inaba H et al (2005) Octreotide as a rapid and effective painkiller for metastatic carcinoid tumor. Endocr J 52(2):277\u2013280. https:\/\/doi.org\/10.1507\/endocrj.52.277","journal-title":"Endocr J"},{"issue":"5","key":"5281_CR6","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.spinee.2007.06.015","volume":"8","author":"M Tanabe","year":"2008","unstructured":"Tanabe M, Akatsuka K, Umeda S, Shomori K, Taniura S, Okamoto H, Kamitani H, Watanabe T (2008) Metastasis of carcinoid to the arch of the axis in a multiple endocrine neoplasia patient: a case report. Spine J Off J North Am Spine Soc 8(5):841\u2013844. https:\/\/doi.org\/10.1016\/j.spinee.2007.06.015","journal-title":"Spine J Off J North Am Spine Soc"},{"issue":"3","key":"5281_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1530\/EJE-08-0153","volume":"159","author":"DM Louren\u00e7o","year":"2008","unstructured":"Louren\u00e7o DM, Toledo RA, Mackowiak II, Coutinho FL, Cavalcanti MG, Correia-Deur JEM, Montenegro F, Siqueira SAC, Margarido LC, Machado MC, Toledo SPA (2008) Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile. Eur J Endocrinol 159(3):259\u2013274. https:\/\/doi.org\/10.1530\/EJE-08-0153","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"5281_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/SLA.0b013e31815efda5","volume":"247","author":"J Norton","year":"2008","unstructured":"Norton J, Venzon D, Berna M et al (2008) Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 (MEN1), and Zollinger-Ellison syndrome (ZES): long-term outcome of a more virulent form of HPT. Ann Surg 247(3):501\u2013510. https:\/\/doi.org\/10.1097\/SLA.0b013e31815efda5","journal-title":"Ann Surg"},{"issue":"8","key":"5281_CR9","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1359\/jbmr.090304","volume":"24","author":"CE Vainicher","year":"2009","unstructured":"Vainicher CE, Chiodini L, Battista C et al (2009) Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity. J Bone Miner Res 24(8):1404\u20131410. https:\/\/doi.org\/10.1359\/jbmr.090304","journal-title":"J Bone Miner Res"},{"issue":"4","key":"5281_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1365-2265.2009.03672.x","volume":"72","author":"FL Coutinho","year":"2010","unstructured":"Coutinho FL, Louren\u00e7o DM, Toledo RA et al (2010) Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy. Clin Endocrinol 72(4):462\u2013468. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03672.x","journal-title":"Clin Endocrinol"},{"issue":"11","key":"5281_CR11","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1002\/jbmr.125","volume":"25","author":"DM Louren\u00e7o","year":"2010","unstructured":"Louren\u00e7o DM, Coutinho FL, Toledo RA (2010) Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism. J Bone Miner Res 25(11):2382\u20132391. https:\/\/doi.org\/10.1002\/jbmr.125","journal-title":"J Bone Miner Res"},{"issue":"6","key":"5281_CR12","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3275\/7880","volume":"35","author":"PH Kann","year":"2012","unstructured":"Kann PH, Bartsch D, Langer P, Waldmann J, Hadji P, Pf\u00fctzner A, Kl\u00fcsener J (2012) Peripheral bone mineral density in correlation to disease-related predisposing conditions in patients with multiple endocrine neoplasia type 1. J Endocrinol Investig 35(6):573\u2013579. https:\/\/doi.org\/10.3275\/7880","journal-title":"J Endocrinol Investig"},{"issue":"4","key":"5281_CR13","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1210\/jc.2014-3659","volume":"100","author":"P Goudet","year":"2015","unstructured":"Goudet P, Dalac A, Le Bras M et al (2015) MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d\u2019\u00e9tude des Tumeurs endocrines. J Clin Endocrinol Metab 100(4):1568\u20131577. https:\/\/doi.org\/10.1210\/jc.2014-3659","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"5281_CR14","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10689-016-9891-7","volume":"15","author":"M Goroshi","year":"2016","unstructured":"Goroshi M, Bandgar T, Lila AR, Jadhav SS, Khare S, Shrikhande SV, Uchino S, Dalvi AN, Shah NS (2016) Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India. Familial Cancer 15(4):617\u2013624. https:\/\/doi.org\/10.1007\/s10689-016-9891-7","journal-title":"Familial Cancer"},{"key":"5281_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1530\/EDM-16-0111","volume":"2016","author":"A Caster\u00e0s","year":"2016","unstructured":"Caster\u00e0s A, Darder L, Zafon C, Hueto JA, Alberola M, Caubet E, Mesa J (2016) Brown tumor of the jaw after pregnancy and lactation in a MEN1 patient. Endocrinol Diabetes Metab Case Rep 2016:16\u20130111. https:\/\/doi.org\/10.1530\/EDM-16-0111","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"11","key":"5281_CR16","doi-asserted-by":"publisher","first-page":"e0166634","DOI":"10.1371\/journal.pone.0166634","volume":"11","author":"J Kong","year":"2016","unstructured":"Kong J, Wang O, Nie M, Shi J, Hu Y, Jiang Y, Li M, Xia W, Meng X, Xing X (2016) Clinical and genetic analysis of multiple endocrine neoplasia type 1-related primary hyperparathyroidism in Chinese. PLoS One 11(11):e0166634. https:\/\/doi.org\/10.1371\/journal.pone.0166634","journal-title":"PLoS One"},{"issue":"1","key":"5281_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4103\/1450-1147.172307","volume":"16","author":"R Ranade","year":"2017","unstructured":"Ranade R, Basu S (2017) Metabolic bone disease in the context of metastatic neuroendocrine tumor: differentiation from skeletal metastasis, the molecular PET-CT imaging features, and exploring the possible etiopathologies including parathyroid adenoma (MEN1) and paraneoplastic humoral hypercalcemia of malignancy due to PTHrP hypersecretion. World J Nucl Med 16(1):62\u201367. https:\/\/doi.org\/10.4103\/1450-1147.172307","journal-title":"World J Nucl Med"},{"issue":"1","key":"5281_CR18","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1186\/s12885-019-6332-7","volume":"19","author":"L Lou","year":"2019","unstructured":"Lou L, Zhou L, Wang W, Li H, Li Y (2019) Atypical ovarian carcinoid tumor with widespread skeletal metastases: a case report of multiple endocrine neoplasia type 1 in a young woman. BMC Cancer 19(1):1107. https:\/\/doi.org\/10.1186\/s12885-019-6332-7","journal-title":"BMC Cancer"},{"key":"5281_CR19","doi-asserted-by":"publisher","unstructured":"Lemmens I, Van de Ven WJ, Kas K et al (1997) Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet 6(7):1177\u20131183. https:\/\/doi.org\/10.1093\/hmg\/6.7.1177","DOI":"10.1093\/hmg\/6.7.1177"},{"issue":"10","key":"5281_CR20","doi-asserted-by":"publisher","first-page":"T147","DOI":"10.1530\/ERC-17-0298","volume":"24","author":"Z Feng","year":"2017","unstructured":"Feng Z, Ma J, Hua X (2017) Epigenetic regulation by the menin pathway. Endocr Relat Cancer 24(10):T147\u2013T159. https:\/\/doi.org\/10.1530\/ERC-17-0298","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"5281_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12020-019-01932-x","volume":"65","author":"A K\u00f6vesdi","year":"2019","unstructured":"K\u00f6vesdi A, T\u00f3th M, Butz H, Sz\u00fccs N, S\u00e1rm\u00e1n B, Pusztai P, T\u0151ke J, Reismann P, F\u00e1klya M, T\u00f3th G, Somogyi A, Borka K, Erdei A, Nagy EV, De\u00e1k V, Valkusz Z, Igaz P, Pat\u00f3cs A, Grolmusz VK (2019) True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome. Endocrine 65(2):451\u2013459. https:\/\/doi.org\/10.1007\/s12020-019-01932-x","journal-title":"Endocrine"},{"key":"5281_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fendo.2018.00533","volume":"9","author":"JM De Laat","year":"2018","unstructured":"De Laat JM, Van Leeuwaarde RS, Valk GD (2018) The importance of an early and accurate MEN1 diagnosis. Front Endocrinol (Lausanne) 9:533. https:\/\/doi.org\/10.3389\/fendo.2018.00533","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"5281_CR23","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML, Endocrine Society (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97(9):2990\u20133011. https:\/\/doi.org\/10.1210\/jc.2012-1230","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"5281_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.6061\/clinics\/2012(Sup01)23","volume":"67","author":"F Giusti","year":"2012","unstructured":"Giusti F, Tonelli F, Brandi ML (2012) Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery? Clinics 67(Suppl 1):141\u2013144. https:\/\/doi.org\/10.6061\/clinics\/2012(Sup01)23","journal-title":"Clinics"},{"issue":"9684","key":"5281_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"Fraser WD (2009) Hyperparathyroidism. Lancet Lond Engl 374(9684):145\u2013158. https:\/\/doi.org\/10.1016\/S0140-6736(09)60507-9","journal-title":"Lancet Lond Engl"},{"issue":"12","key":"5281_CR26","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1007\/s10067-016-3450-3","volume":"35","author":"R Pappu","year":"2016","unstructured":"Pappu R, Jabbour SA, Reginato AM, Reginato AJ (2016) Musculoskeletal manifestations of primary hyperparathyroidism. Clin Rheumatol 35(12):3081\u20133087. https:\/\/doi.org\/10.1007\/s10067-016-3450-3","journal-title":"Clin Rheumatol"},{"key":"5281_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.6061\/clinics\/2012(Sup01)17","volume":"67","author":"DM Louren\u00e7o","year":"2012","unstructured":"Louren\u00e7o DM, Coutinho FL, Toledo RA et al (2012) Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1. Clinics 67:99\u2013108. https:\/\/doi.org\/10.6061\/clinics\/2012(Sup01)17","journal-title":"Clinics"},{"issue":"39","key":"5281_CR28","doi-asserted-by":"publisher","first-page":"40267","DOI":"10.1074\/jbc.M401312200","volume":"279","author":"H Sowa","year":"2004","unstructured":"Sowa H, Kaji H, Hendy GN, Canaff L, Komori T, Sugimoto T, Chihara K (2004) Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2. J Biol Chem 279(39):40267\u201340275. https:\/\/doi.org\/10.1074\/jbc.M401312200","journal-title":"J Biol Chem"},{"issue":"4","key":"5281_CR29","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/cdd.2016.165","volume":"24","author":"P Liu","year":"2017","unstructured":"Liu P, Lee S, Knoll J, Rauch A, Ostermay S, Luther J, Malkusch N, Lerner UH, Zaiss MM, Neven M, Wittig R, Rauner M, David JP, Bertolino P, Zhang CX, Tuckermann JP (2017) Loss of menin in osteoblast lineage affects osteocyte\u2013osteoclast crosstalk causing osteoporosis. Cell Death Differ 24(4):672\u2013682. https:\/\/doi.org\/10.1038\/cdd.2016.165","journal-title":"Cell Death Differ"},{"issue":"4","key":"5281_CR30","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/jcb.21660","volume":"103","author":"A Kawamata","year":"2008","unstructured":"Kawamata A, Izu Y, Yokoyama H, Amagasa T, Wagner EF, Nakashima K, Ezura Y, Hayata T, Noda M (2008) JunD suppresses bone formation and contributes to low bone mass induced by estrogen depletion. J Cell Biochem 103(4):1037\u20131045. https:\/\/doi.org\/10.1002\/jcb.21660","journal-title":"J Cell Biochem"},{"issue":"4","key":"5281_CR31","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3340\/jkns.2015.58.4.389","volume":"58","author":"E Sonmez","year":"2015","unstructured":"Sonmez E, Tezcaner T, Coven I, Terzi A (2015) Brown tumor of the thoracic spine: first manifestation of primary hyperparathyroidism. J Korean Neurosurg Soc 58(4):389\u2013392. https:\/\/doi.org\/10.3340\/jkns.2015.58.4.389","journal-title":"J Korean Neurosurg Soc"},{"issue":"2","key":"5281_CR32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3342\/ceo.2013.6.2.110","volume":"6","author":"JH Lee","year":"2013","unstructured":"Lee JH, Chung SM, Kim HS (2013) Osteitis fibrosa cystica mistaken for malignant disease. Clin Exp Otorhinolaryngol 6(2):110\u2013113. https:\/\/doi.org\/10.3342\/ceo.2013.6.2.110","journal-title":"Clin Exp Otorhinolaryngol"},{"issue":"Suppl 1","key":"5281_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000051856","volume":"62","author":"M Mignon","year":"2000","unstructured":"Mignon M (2000) Natural history of neuroendocrine enteropancreatic tumors. Digestion 62(Suppl 1):51\u201358. https:\/\/doi.org\/10.1159\/000051856","journal-title":"Digestion"},{"key":"5281_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1572-0241.2006.00367.x","volume":"101","author":"L Thomas-Marques","year":"2006","unstructured":"Thomas-Marques L, Murat A, Delemer B, Penfornis A, Cardot-Bauters C, Baudin E, Niccoli-Sire P, Levoir D, Choplin HB, Chabre O, Jovenin N, Cadiot G, Groupe des Tumeurs Endocrines (GTE) (2006) Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. Am J Gastroenterol 101:266\u2013273. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00367.x","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"5281_CR35","first-page":"184","volume":"44","author":"WG Meijer","year":"2003","unstructured":"Meijer WG, van der Veer E, Jager PL et al (2003) Bone metastases in carcinoid tumors: clinical features, imaging characteristics, and markers of bone metabolism. J Nucl Med Off Publ Soc Nucl Med 44(2):184\u2013191","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"2","key":"5281_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00268-009-0290-1","volume":"34","author":"P Goudet","year":"2010","unstructured":"Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P, Niccoli P, M\u00e9n\u00e9gaux F, Chabrier G, Borson-Chazot F, Tabarin A, Bouchard P, Delemer B, Beckers A, Bonithon-Kopp C (2010) Risk factors and causes of death in MEN1 disease. A GTE (Groupe d\u2019Etude des Tumeurs Endocrines) cohort study among 758 patients. World J Surg 34(2):249\u2013255. https:\/\/doi.org\/10.1007\/s00268-009-0290-1","journal-title":"World J Surg"},{"key":"5281_CR37","first-page":"1026","volume-title":"Dermatology","author":"SJ Bayliss","year":"2018","unstructured":"Bayliss SJ, Kumar MG, Hern\u00e1ndez-Mart\u00edn A, Burton BK, Cohen BA, Itin PH, Bree AF, Sybert VP (2018) Other genodermatoses. In: Bolognia JL (ed) Dermatology, 4th edn. Elsevier, New York, pp 1026\u20131056","edition":"4"},{"issue":"4","key":"5281_CR38","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/1097-0215(20000815)87:4<463::aid-ijc1>3.0.co;2-8","volume":"87","author":"B Nord","year":"2000","unstructured":"Nord B, Platz A, Smoczynski K, Kyt\u00f6l\u00e4 S, Robertson G, Calender A, Murat A, Weintraub D, Burgess J, Edwards M, Skogseid B, Owen D, Lassam N, Hogg D, Larsson C, Teh BT (2000) Malignant melanoma in patients with multiple endocrine neoplasia type 1 and involvement of the MEN1 gene in sporadic melanoma. Int J Cancer 87(4):463\u2013467. https:\/\/doi.org\/10.1002\/1097-0215(20000815)87:4<463::aid-ijc1>3.0.co;2-8","journal-title":"Int J Cancer"},{"issue":"5","key":"5281_CR39","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1365-2265.2004.02030.x","volume":"60","author":"D Nehar","year":"2004","unstructured":"Nehar D, Lombard-Bohas C, Olivieri S, Claustrat B, Chayvialle JA, Penes MC, Sassolas G, Borson-Chazot F (2004) Interest of chromogranin A for diagnosis and follow-up of endocrine tumours. Clin Endocrinol 60(5):644\u2013652. https:\/\/doi.org\/10.1111\/j.1365-2265.2004.02030.x","journal-title":"Clin Endocrinol"},{"issue":"2","key":"5281_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1053\/j.seminoncol.2017.07.001","volume":"44","author":"T Enzler","year":"2017","unstructured":"Enzler T, Fojo T (2017) Long-acting somatostatin analogues in the treatment of unresectable\/metastatic neuroendocrine tumors. Semin Oncol 44(2):141\u2013156. https:\/\/doi.org\/10.1053\/j.seminoncol.2017.07.001","journal-title":"Semin Oncol"},{"issue":"9","key":"5281_CR41","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1210\/jc.2007-1215","volume":"93","author":"MR Rubin","year":"2008","unstructured":"Rubin MR, Bilezikian JP, McMahon DJ et al (2008) The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 93(9):3462\u20133470. https:\/\/doi.org\/10.1210\/jc.2007-1215","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"5281_CR42","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.lpm.2018.03.005","volume":"47","author":"A Al-Salameh","year":"2018","unstructured":"Al-Salameh A, Baudry C, Cohen R (2018) Update on multiple endocrine neoplasia type 1 and 2. Presse Med 47(9):722\u2013731. https:\/\/doi.org\/10.1016\/j.lpm.2018.03.005","journal-title":"Presse Med"},{"issue":"1","key":"5281_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2265.2009.03662.x","volume":"72","author":"J Burgess","year":"2010","unstructured":"Burgess J (2010) How should the patient with multiple endocrine neoplasia type 1 (MEN 1) be followed? Clin Endocrinol 72(1):13\u201316. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03662.x","journal-title":"Clin Endocrinol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05281-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05281-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05281-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T23:40:13Z","timestamp":1626219613000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05281-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["5281"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05281-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"assertion":[{"value":"6 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}